"We help patients in San Antonio's Southeast side feel better. In the Mission Trail office, we treat a full range of urologic conditions such as: Prostate Cancer (from diagnosis to advanced-stage treatment) Female Urinary Incontinence Kidney Stones Erectile Dysfunction Overactive Bladder (OAB) Urinary Retention Enlarged Prostate (BPH) Low Testosterone (Low T) Pelvic Prolapse Hematuria (Blood in urine) Kidney Cancer Bladder Cancer Urinary Tract Infection And perform urology procedures like: Vasectomy Vasectomy Reversal Prostate exams / PSA tests Prostate Cancer Robotic Surgery (prostatectomy) Lithotripsy UroLift for BPH Interstim for OAB Adult Circumcision"

During the past decade, Urology San Antonio Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 18 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology San Antonio Research" #1 sponsor was "Ferring Pharmaceuticals" with 11 trials, followed by "GTx" with 6 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Boston Scientific Corporation" with 4 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology San Antonio Research" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Immunex Corporation" with 1 trials as a collaborator and "Ockham Development Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Urology San Antonio Research" are "Prostate Cancer" (23 trials), "Prostatic Neoplasms" (5 trials), "Stress Urinary Incontinence" (5 trials), "Urinary Bladder Neoplasms" (4 trials) and "Benign Prostatic Hyperplasia" (2 trials). Many other conditions were trialed in "Urology San Antonio Research" in a lesser frequency.

Most popular intervention types in "Urology San Antonio Research" are "Drug" (57 trials), "Biological" (7 trials), "Other" (6 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Degarelix" (9 trials), "Laboratory Biomarker Analysis" (5 trials), "Pharmacological Study" (5 trials) and "Therapeutic Conventional Surgery" (3 trials). Other intervention names were less common.

The vast majority of trials in "Urology San Antonio Research" are 44 trials for "Male" genders, 18 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Urology San Antonio Research". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Urology San Antonio Research, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Urology San Antonio Research, 3 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".